Facts
- HQ
- 30 Wall Street, 12th floor New York, NY, 10005 United States
- Sectors
- Venture Capital, Life Sciences Investing
Curi Bio raises $10M to advance iPSC-based 3D tissue drug-discovery platforms including Mantarray
Seattle-based Curi Bio raised $10 million in Series A financing to advance its human iPSC-based drug discovery platforms, including 3D engineered tissue products like Mantarray and Cytostretcher. The company provides customized assay and screening services for cardiac, musculoskeletal and neuromuscular models and has prior funding including $6M this spring and over $6M in NIH grants.
Lightspeed Microscopy raises $4M Series A from Dynamk Capital to commercialize 3D pathology imaging platform
Lightspeed Microscopy, a Seattle startup spun out of the University of Washington, raised $4 million in a Series A led by Dynamk Capital to commercialize an end-to-end 3D pathology microscopy platform that optically clears and rapidly scans intact samples, then uses cloud-based AI to produce 3D images for pharma and clinical use.
Startup Haven launches Startup Haven Ventures, adds Westerdal, Yu and Mbemba; PSL promotes three; Adam Selipsky named AWS CEO
Startup Haven, founded by Bob Crimmins, launched Startup Haven Ventures and expanded its team to include Jay Westerdal, Arry Yu and Claudius Mbemba; the fund targets pre-seed, capital-efficient companies with a Pacific Northwest focus and made its first investment in Verdi. Seattle’s Pioneer Square Labs promoted Palvi Mehta, David Zager and Ben Gilbert; separately, Tableau CEO Adam Selipsky will become AWS CEO, replacing Andy Jassy.
